COTI-2, a Novel Small Molecule That Is Active Against Multiple Human Cancer Cell Lines in Vitro and in Vivo

Oncotarget - United States
doi 10.18632/oncotarget.9133
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

A Novel Selective Small-Molecule PI3K Inhibitor Is Effective Against Human Multiple Myeloma in Vitro and in Vivo

Blood Cancer Journal
OncologyHematology
2013English

Eg-011 Is a Novel Small Molecule With in Vitro and in Vivo Anti-Tumor Activity Against Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

A Novel Small Inhibitor, LLL12, Targets STAT3 in Non‑small Cell Lung Cancer In�vitro and In�vivo

Oncology Letters
Cancer ResearchOncology
2018English

Rifapentine Is Active in Vitro and in Vivo Against Toxoplasma Gondii.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1996English

Antitumor Activities of JTP-74057 (GSK1120212), a Novel MEK1/2 Inhibitor, on Colorectal Cancer Cell Lines in Vitro and in Vivo

International Journal of Oncology
Cancer ResearchOncology
2011English

AZD3514: A Small Molecule That Modulates Androgen Receptor Signaling and Function in Vitro and in Vivo

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Correction: A Novel Small-Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth in Vitro and in Vivo

Molecular Cancer Therapeutics
Cancer ResearchOncology
2010English

A Novel Circular Invasion Assay Mimics in Vivo Invasive Behavior of Cancer Cell Lines and Distinguishes Single-Cell Motility in Vitro

BMC Cancer
Cancer ResearchOncologyGenetics
2008English

Molecular Imaging of Cell Death in Vivo by a Novel Small Molecule Probe

Apoptosis : an international journal on programmed cell death
Cell BiologyPharmacologyBiochemistryClinical BiochemistryCancer ResearchPharmaceutical Science
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy